Page last updated: 2024-08-21

cyproterone acetate and docetaxel anhydrous

cyproterone acetate has been researched along with docetaxel anhydrous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buijs, JT; Culig, Z; Grimm, S; Hemmer, DM; Hwang, MS; Kroon, J; Marijt, KA; Masood, M; Meijer, OC; Metselaar, JM; Puhr, M; Storm, G; van der Horst, G; van der Pluijm, G	1

Other Studies

1 other study(ies) available for cyproterone acetate and docetaxel anhydrous

Article	Year
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer. Endocrine-related cancer, 2016, Volume: 23, Issue:1 Topics: Apoptosis; Cyproterone Acetate; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Male; Mifepristone; Prostatic Neoplasms; Receptors, Glucocorticoid; Taxoids; Tumor Cells, Cultured	2016

Article

Year

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.

Endocrine-related cancer, 2016, Volume: 23, Issue:1

Topics: Apoptosis; Cyproterone Acetate; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Male; Mifepristone; Prostatic Neoplasms; Receptors, Glucocorticoid; Taxoids; Tumor Cells, Cultured

2016